Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response.

MLA

Thompson, Kevin J., et al. “Luminal Androgen Receptor Breast Cancer Subtype and Investigation of the Microenvironment and Neoadjuvant Chemotherapy Response.” NAR Cancer, vol. 4, no. 2, June 2022, p. zcac018. EBSCOhost, https://doi.org/10.1093/narcan/zcac018.

APA

Thompson, K. J., Leon-Ferre, R. A., Sinnwell, J. P., Zahrieh, D. M., Suman, V. J., Metzger, F. O., Asad, S., Stover, D. G., Carey, L., Sikov, W. M., Ingle, J. N., Liu, M. C., Carter, J. M., Klee, E. W., Weinshilboum, R. M., Boughey, J. C., Wang, L., Couch, F. J., Goetz, M. P., & Kalari, K. R. (2022). Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response. NAR Cancer, 4(2), zcac018. https://doi.org/10.1093/narcan/zcac018

Chicago

Thompson, Kevin J, Roberto A Leon-Ferre, Jason P Sinnwell, David M Zahrieh, Vera J Suman, Filho Otto Metzger, Sarah Asad, et al. 2022. “Luminal Androgen Receptor Breast Cancer Subtype and Investigation of the Microenvironment and Neoadjuvant Chemotherapy Response.” NAR Cancer 4 (2): zcac018. doi:10.1093/narcan/zcac018.